Fujifilm has selected Holly Springs of North Carolina as the location for its new $2 billion cell culture manufacturing facility in the US. In January 2021, the Japanese conglomerate announced setting up such a facility with an aim to fast-track the growth of its biopharmaceutical contract development and manufacturing business (CDMO). The end-to-end cell culture […]
Novavax has signed an agreement with FUJIFILM Diosynth Biotechnologies (FDB), a US-based contract development and manufacturing organization (CDMO), for the manufacturing of bulk drug substance for NVX-CoV2373, the former’s COVID-19 vaccine candidate. FUJIFILM Diosynth Biotechnologies’ facility in Morrisville, North Carolina has started production of the first batch of NVX-CoV2373. The arrangement between the two firms […]